Printer Friendly

TRAVIS PARTNERS EXERCISES VIRAL TESTING SYSTEMS CORPORATION WARRANTS

 HOUSTON, May 28 /PRNewswire/ -- Viral Testing Systems Corporation (AMEX: VTS) announced today that Travis Partners, G.P., the largest VTS shareholder, recently exercised all of its 1.26 million VTS warrants at a price of $1.89 per warrant. Travis issued a 10 percent note, due Dec. 31, 1993, for the full amount of the purchase price of the shares. The note is secured by the VTS shares acquired through exercise of the warrants and the shares of Lone Star Casino Corporation acquired pursuant to the recent spinoff of Lone Star by Viral Testing Systems. The proceeds of any sales of such shares by Travis shall be first applied in payment of the note and interest.
 VTS owns the exclusive marketing and distribution rights in the United States and the Western Hemisphere for FLUOROGNOST HIV-1 IFA, the only FDA-approved test that can both screen and confirm for the HIV virus, and can report results within 90 minutes.
 Paul Montle, president and chief executive officer of VTS and also the managing general partner of Travis Partners, said "The warrant exercise is a positive step for VTS and Travis Partners. The additional funds that VTS will receive when the note is paid will give VTS more flexibility to explore acquisition opportunities in other areas of medical diagnostics. Travis Partners feels it will gain substantially over the long-term for this commitment to the future of Viral Testing Systems."
 For further information, please contact Viral Testing Systems Corporation; 600 Travis Street, Suite 4750; Houston, Texas 77002; 713-228-1544, attention: Holly Vaughan, Investor Relations.
 -0- 5/28/93
 /CONTACT: Holly Vaughan, investor relations of Viral Testing Systems Corporation, 713-228-1544/
 (VTS)


CO: Viral Testing Systems Corporation ST: Texas IN: MTC SU:

PS-OS -- NY040 -- 3439 05/28/93 14:21 EDT
COPYRIGHT 1993 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1993 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:May 28, 1993
Words:293
Previous Article:RESPONSE TO ACTION AGAINST USAIR PILOTS
Next Article:BLACKROCK FINANCIAL MANAGEMENT LP LISTS FOUR NEW FUNDS ON THE AMERICAN STOCK EXCHANGE
Topics:


Related Articles
DRUG SCREENING SYSTEMS WARRANT EXERCISE EXCEEDS $5.2 MILLION
SOMANETICS CORPORATION ANNOUNCES REDEMPTION OF CLASS A, CLASS B WARRANTS
TELECONCEPTS RECEIVES FIRM COMMITMENTS FOR EQUITY PLACEMENT IN EXCESS OF MINIMUM REQUIRED FOR MERGER WITH THERMASCAN, INC.
VIRAL TESTING SYSTEMS ANNOUNCES SALE OF ITS TELEPHONE BUSINESS
VIRAL TESTING SYSTEMS ENTERS BILLION DOLLAR HOME HEALTH CARE MARKET WITH PURCHASE OF BIOTEL CORP.
BIOCIRCUITS CORPORATION RECEIVES $8.7 MILLION IN COMPLETION OF PRIVATE PLACEMENT
ANGEION RAISES $11 MILLION IN WARRANT EXERCISE
FLUOROSCAN IMAGING SYSTEMS, INC. (NASDAQ) CALLS FOR THE REDEMPTION OF ALL OF ITS OUTSTANDING REDEEMABLE COMMON STOCK PURCHASE WARRANTS
FLUOROSCAN IMAGING SYSTEMS, INC. (NASDAQ) DELAYS WARRANT REDEMPTION DATE TO JULY 31, 1996
Sontra Medical Corporation Completes $3.1 Million Financing.

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters